Tricks and Tips

Sunday, June 26, 2016

Anti Plagiarism Strategies for Research Papers

Plagiarism is the reproduction or appropriation of someone else’s work without proper attribution; passing off as one’s own the work of someone else. Self-Plagiarism is copying material you have previously produced and passing it off as a new production. This can potentially violate copyright protection, if the work has been published, and is banned by most academic policies.


Plagiarism on research papers can be of different types which includes: 
  1.  Downloading a free research paper : Many of these papers have been written and shared by others. Free papers are often of poor quality, in both mechanics and content. Some of the papers are surprisingly old (with citations being no more recent than the seventies). 
  2. Buying a paper from commercial sites: These papers can be good--and sometimes they are too good. If you have given students an in-class writing assignment, you can compare the quality and be quite enlightened. 
  3. Copying an article from the Web or an online or electronic database: Only some of these articles will have the quantity and type of citations that academic research papers are expected to have. If you receive a well-written, highly informed essay without a single citation (or with just a few), it may have been copied wholesale from an electronic source. 
  4. Copying a paper from a local source: Papers may be copied from students who have taken your course previously, from fraternity files, or from other paper-sharing sources near campus. If you keep copies of previous papers turned in to you, they can be a source of detection of this particular practice. Cutting and pasting to create a paper from several sources.  The introduction and conclusion are often student-written and therefore noticeably different from and weaker than the often glowing middle. 
  5. Quoting less than all the words copied: This practice includes premature end quotation marks or missing quotation marks. A common type of plagiarism occurs when a student quotes a sentence or two, places the end quotation mark and the citation, and then continues copying from the source. Or the student may copy from the source verbatim without any quotation marks at all, but adding a citation, implying that the information is the student's summary of the source. Checking the citation will expose this practice. 
  6. Faking a citation: In lieu of real research, some students will make up quotations and supply fake citations. The fake citation can be either completely fabricated (The American Journal of Asymmetric Induction Studies), or it can reference a real source (book, journal, or Web site) which contains no such article or words that have supposedly been used. You can discover this practice by randomly checking citations. If you require several Web or other electronic sources for the paper, these can be checked quickly.

Tuesday, June 21, 2016

What makes a Great Journal Paper?

Dear Readers..!!! Thanks for visiting my blog...!!!

Writing for Journals? What makes a great journal paper?

And how do you know where to start? Who can help you? What are journal editors looking for? How long will it take and are you really ready to publish? These fundamental questions (and more!) are asked by millions of researchers each year so watch the lectures and take the training to make sure you know the pitfalls and secrets of success.



Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

6 Best colleges for Every Student round the Globe : Join and get Certified

Dear Readers..!!! Thanks for visiting my blog...!!!




Interactive training courses guide you carefully through a topic and test your knowledge along the way. Average completion time is 15-30 minutes. 



Online lectures present a topic by leading experts and engage in Q&A towards the end to boost the discussion. Average completion time is 15 minutes. LIVE online lectures present a topic by leading experts and are followed by a live Q&A which you can join in! Average completion time is 50 minutes.


Discuss and learn about the latest developments in publishing with our Big Ideas blog posts, webinars, feature articles, discussions and live events.



Researching and writing can absorb a huge amount of time. It is easy to forget that engaging with the world around you is just as important when it comes to establishing a successful career and becoming a widely-recognized researcher. 

Staying on top of developments within your subject area will not only benefit your career, it might give you new insights into the topic you've been working on, put you in contact with the experts in your field and put you on the right track to getting the recognition you deserve.


This college contains free tools to help you get ready to publish. They'll help you keep up-to-date with current research, manage your personal online library, and create bibliographies for your articles. For articles you've already published, you can use free tools to share and promote your work.


A successful research career hinges not only on getting that single paper published, it requires you to think ahead about where you want to be 3 to 5 years from now, or even 10 to 15 years. You need to know where to find the funding to keep you going, so that when new opportunities present themselves, you are ready to take the next step.


Many organizations exist around the world that are dedicated to supporting the careers and progress of researchers today. Whether it be from a policy level, creating training resources, providing a voice and advice or organizing events - these organizations work tirelessly to improve the future of researchers in academia. Listed below are just a handful of recommended organizations we would like to highlight.

Happy Blogging...!!!

Friday, June 17, 2016

Palliative care e-learning course for healthcare professionals in India

Dear Readers..!!! Thanks for visiting my blog...!!!

Our sincere thanks to Prof. Dr. Gayatri Palat for sharing this valuable info with us.

ecancer provides e-learning courses for free to the oncology community. Our resources cover a variety of topics and have been developed in partnership with leading organisations and individuals. Our e-learning is impactful and focuses on the end goal of improving patient care and outcomes. 



Our resources are completely free of charge; all we ask is that you register for the ecancer club so that we are able to record your learning.


View Complete details Here

Happy Blogging...!!!

 Public Health Research Initiative (PHRI) Research Grant: 2016-17

Dear Readers..!!! Thanks for visiting my blog...!!!

Public Health Research Initiative (PHRI)

Public Health foundation of India (PHFI) in collaboration with Science and Engineering Research Board (SERB, A Statutory Body under Department of Science and Technology (DST)) aims to set up anextramural fund to provide the Indian researchers focused on public health from institutions of repute, as per an established process. PHRI will enable young Indian researchers to carry out clearly defined research project at a place of their choice up to a period of 36 months.

Project Duration and Cost

These grants will be awarded for research studies of public health importance in India. The estimated amount of the available research grant is limited to 30 Lakh INR per Research Grant. The total duration of the grant will not exceed more than THREE years.

Eligibility Criteria

The applicant must possess a Post-Graduate degree from an accredited institution in any domain related to public health, including medical and non-medical sciences, nutrition, physiotherapy, dentistry, pharmacy, nursing, social sciences, law and humanities. It would be desirable if the applicant has a doctoral degree. (Applications related to Biomedical, Biophysics and biochemistry are excluded from PHRI Research Grants)

Age Criteria

The applicant must be 40 years or less at the time of applying for the PHRI Research Grant, age relaxation of 5 years is applicable for female or if applicant belong to SC/ST/OBC then

Application procedure:

Candidates are requested to apply online

a) Online application formats with detailed guidelines are available at the website www.phfi.org Guidelines for Submitting a proposal

This should include the following
  1. Title of the study
  2. Overall goal
  3. Broad Objective
  4. Specific objectives
  5. Methodology
  6. Analysis plan
  7. Expected outcome
  8. Timeline
  9. Implications for future research
  10. References
  11. Dissemination and publication plan
  12. Itemized budget along with justification for each item
  13. Curriculum vitae of investigator listed in the grant application
Word limit: Not more than 3000 words (excluding references, Dissemination plan, Itemized budget and Curriculum Vitae) Font Style: Times New Roman Font Size: 12 with Line Spacing 1.5

Kindly note following should be mentioned while sending the grant application:

Area of work:

Area proposed by candidate should be clearly defined research area in any aspect of Public Health like Public Health Nutrition, Non Communicable Diseases, Infectious Diseases and Public Health Policy etc.

Place of work:

A project site in India, depending on the demand of the research study.

The PHFI reserves the right to reject the Research Grant application in case candidate DOES NOT FULFILL minimum qualification or supplies any false information.

Public Health Research Initiative (PHRI) Research Grant: 2016

Online submission will close by 30 June 2016 after 5:00 PM.


Happy Blogging...!!!

Saturday, June 4, 2016

Elsevier Student Ambassador - 2016 : Apply Today

Dear Readers..!!! Thanks for visiting my blog...!!!

Elsevier is the world's leading information resource provider. Elsevier Student Ambassador (ESA) programme is one of the most thriving programmes of Elsevier South Asia giving you the chance to become a liaison between Elsevier and your college/University. The mandate of this programme is to have student ambassadors from health sciences community across South Asia who can connect with each other and open gates to unexplored opportunities in their fields.

Joining this programme empowers you to connect with your fellow ESA's across the South Asia, get access to the latest from Elsevier Information repository, and be a part of the team that will help in redefining the health care education in South Asia.


As a student ambassador, you will get many opportunities to upgrade your skills, connect with your peers and be the face of Elsevier. You would get an exclusive chance to become expert reviewers of Elsevier and also an opportunity to author with it. You would get to attend significant CMEs, author events, product launch events, conferences, group discussions etc., apart from having free trials of the rich Elsevier products once you are chosen as the ESA. And much more..

How to apply : "Become an ESA"

1) Register by entering your details

2) Login with your email id

3) Read the terms and conditions

4) Be a part of the medical quiz competition and answer 30 questions in 15 minutes and submit

5) Submit an Essay regarding the topic mentioned

6) Wait for the telephonic Interview

New Opportunities this year:
  1. Great Opportunity to Upgrade your skills through various Elsevier portals.
  2. Great opportunity to Author with Elsevier.
  3. Exclusive chance to become an expert Elsevier reviewer.
  4. Attend events, Product launch and Conferences. 


For those who want to skip Quiz; you need to get a referral from the already existing Ambassadors or Mentors.


Every year 10,000 students apply for this programme from various counties of which only 100 will be selected and get benefited, hope you will be one among them this year. All the best. 


Official Website: "Elsevier India"


Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India
Elsevier Student Ambassador - South Asia

Sunday, May 29, 2016

World's Top 100 Pharmaceutical Universities : 2016 QS Ranking

Dear Readers..!!! Thanks for visiting my blog...!!!

Celebrating 100th blog post with 1.34 Lakh visitors


Here is the list of World's Top 100 Pharmacy universities as per 2016 QS rankings which is useful for your higher studies and bright career. 

Wishing you all the best. 

Keep Visiting our blog for more updates. 


Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

How to Become a Registered Pharmacist in India

Dear Readers..!!! Thanks for visiting my blog...!!!



Application Procedure : 

The candidate has to be Registered at your respective State Pharmacy Councils through this procedure


Happy Blogging...!!!

Regards,
Deepak Kumar Bandari,
Pharm.D Intern,
Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

    Thursday, May 26, 2016

    Top 50 Pharmacy Colleges in India : MHRD 2016 Report

    Dear Readers..!!! Thanks for visiting my blog...!!!



    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia

    Pharmacopoeia Scientists : Salary upto 12 Lakhs per annum

    Dear Readers..!!! Thanks for visiting my blog...!!!





    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India

    Elsevier Student Ambassador - South Asia

    Wednesday, May 25, 2016

    Good News for Pharm.D graduates : Tata Memorial Centre Fellowships

    Dear Readers..!!! Thanks for visiting my blog...!!!



    Apply Here

    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia

    Monday, May 23, 2016

    69th World Health Assembly Started Today : Watch Live Here

    Dear Readers..!!! Thanks for visiting my blog...!!!
    The Sixty-ninth session of the World Health Assembly (WHA) takes place in Geneva 23-28 May 2016. The Health Assembly is the supreme decision-making body of WHO. It is attended by delegations from all WHO Member States. Its main functions are to determine the policies of the Organization, supervise financial policies, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland.


    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia

    Cell Phone Radiation and Cancer: The Top 5 Phones With The Highest Radiation

    Dear Readers..!!! Thanks for visiting my blog...!!!

    Mobile phones expose us to harmful levels of radiation. Moreover, these gadgets emit dangerous, non-ionizing form of electromagnetic radiation and our bodies absorb this radiation and as a result we struggle with numerous health problems.

    A study conducted at the Weizmann Institute of Science in Israel, published in the Biochemical Journal, found that a single use of your mobile for 10 minutes triggers changes in your brain cells that are closely related with cell division and cancer.


    “As of now, with only 10-12 years exposure which only continues to increase dramatically, there is a high chance of increase in the rate of brain cancer”- stated Dr. John Bucher, the Associate Director of the National Institute of Health, National toxicology program. Moreover, he added that children have a skull configuration which allows a deeper penetration of the cell phone radiation and they are at greater risk. Therefore, protect your healthy.

    This video below lists the top 5 mobile phones that you need to avoid!


    For more Updates, follow us on Facebook

    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India

    Elsevier Student Ambassador - South Asia

    Free Online Course : Preventing the Zika Virus


    Dear Readers..!!! Thanks for visiting my blog...!!!

    About the Course:

    The Zika virus is suspected to be the cause of cases of microcephaly in newborns in South America, and this outbreak has now been declared a Public Health Emergency of International Concern by the World Health Organization. With global attention towards this disease increasing rapidly, it is becoming clear that there is limited knowledge around how the carriers, or vectors, of Zika, are best avoided and controlled.


    Focus on the Zika virus:

    This free online course will begin by considering the science behind the outbreak to try to understand where the Zika virus has come from, its symptoms, and its effect on infected individuals. Our attention will then turn towards the vector primarily responsible for transmission of Zika: theAedes mosquito.

    Explore the biology of Aedes mosquitoes:

    We will introduce the Aedes mosquito and examine its lifecycle, behaviour, and distribution across the world, before reflecting upon the important role it plays in spreading Zika virus. Without a vaccine, prevention and control relies on reducing numbers of mosquitoes and the contact they have with people, so an understanding of the biology of Aedes is vital.

    Discover vector control methods:

    A range of methods employed to control the Aedes mosquito will be highlighted, including the use, importance, and suitability of repellents, impregnated clothing, larval control, insecticide spraying, and insecticide treated nets. The vectors of Zika virus also transmit dengue, yellow fever and the chikungunya virus, meaning there is potential to apply these techniques in other settings.

    Learn together and from those on the front line in South America

    Learners will come from all over the world with their own diverse experiences and interests. You will have the opportunity to exchange thoughts and ideas through course discussion, and hear first-hand accounts from experts and individuals working in the field in South America. 
    Contributors include:
    1. Dr Mary Cameron, Reader in Medical Entomology
    2. Dr Jo Lines, Reader of Malaria Control and Vector Biology
    3. Professor Laura Rodrigues, Professor of Infectious Disease Epidemiology and working with the Microcephaly Epidemic Research Group in BrazilProfessor Jimmy Whitworth, Professor of International Public Health.

    Support for Portuguese and Spanish speakers will be available throughout the course, including video subtitles, transcripts, and translations of other key materials.

    About ARCTEC:

    ARCTEC is an integral part of the Department of Disease Control at the London School of Hygiene & Tropical Medicine and a world-leading independent test centre for consultancy and the evaluation and development of arthropod pest control technologies.

    REQUIREMENTS:

    This course is designed for anyone with an interest in learning about Zika virus vector control. It is relevant to workers newly drafted into vector control work, NGO employees in affected countries, students taking a healthcare or science-related degree, medical students and postgraduates wishing to complement their studies, and academic staff in aligned disciplines.

    Join the Course Here

    For more Updates, follow us on Facebook

    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia

    Sunday, May 22, 2016

    New Study Reveals Tamoxifen Reduces Breast Cancer Rates by Nearly a Third for 20 Years

    Dear Readers..!!! Thanks for visiting my blog...!!!

    A new study has shown that the preventive effect of the breast cancer drug, tamoxifen, remains virtually constant for at least 20 years, with breast cancer rates reduced by around 30 percent. Median 16-year follow-up results from the IBIS-I (International Breast Cancer Intervention-I) trial show a 29% lower risk for developing breast cancer among women who had been randomly assigned to five years of tamoxifen than for women assigned to five years of placebo.


    “Tamoxifen is a well-established and effective treatment for certain breast cancers, but we now have evidence of its very long-term preventive benefits…" said Professor Jack Cuzick, IBIS-I lead author and Head of the Centre for Cancer Prevention at Queen Mary University of London. Professor Cuzick underscored the “strong and unabated” 20-year preventive effect of breast cancer resulting in a reduction in breast cancer rates of around a third. “We hope these results will stimulate more women, particularly younger women, to consider treatment options for breast cancer prevention if they have a family history of the disease or other major risk factors.”

    The IBIS-I results were presented on December 11, 2014 at the San Antonio Breast Cancer Symposium (SABCS 2014) in Texas and published simultaneously in The Lancet Oncology. SABCS is an international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.

    It was organized by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The IBIS-I study, which began recruitment in 1992, enrolled 7,154 pre- and post-menopausal women aged from 35 to 70 years at high risk for breast cancer primarily because of a family history. They were randomly assigned to receive either tamoxifen 20 mg daily for five years (3,579) or placebo (3,575).

    Hormone replacement therapy was allowed during the trial and was used by 49.5% in the placebo group, and approximately 35% of women in each group had had a hysterectomy. The median age at enrollment was 50.8 years in each group. At a median of 16 years of follow-up (longest follow-up 22 years), there were 601 breast cancers reported, 251 (7.0%) occurring in women who took tamoxifen, and 351 (9.8%) in women who took placebo.

    In subanalysis, the most pronounced reductions in risk were seen for invasive estrogen-receptor-positive (ER+) breast cancer and ductal carcinoma in situ. However, tamoxifen did not significantly reduce the risk for invasive estrogen-receptor-negative (ER-) breast cancer. The extended analysis of the IBIS-I trial was announced a year after the first results of the IBIS-II trial were released, which found taking the breast cancer drug anastrozole (an aromatase inhibitor) for five years reduced the chances of post-menopausal, high-risk women developing the disease by 53% compared with women who took a placebo. Professor Cuzick concludes: “For most post-menopausal women, an aromatase inhibitor such as anastrozole should be the drug of choice, as it is more effective than tamoxifen and has fewer side effects. However… “…for most premenopausal, high-risk women, tamoxifen remains the only drug of choice for breast cancer prevention and it is a good one, as shown by this new evidence.”

    Most Filipino patients cannot afford cost of breast cancer screening, treatment

    In the Philippines, which has the highest rate of breast cancer in Asia, low awareness may not be the main reason why the majority of breast cancer cases are not diagnosed early. “Most Filipino patients cannot afford the cost of diagnostic tests and treatments for breast cancer,” states the 2010 Philippine Cancer Facts and Estimates, a document published by the Department of Health and Philippine Cancer Society.

    Experts recommend that women, starting at the age of 30, perform monthly self breast examination (SBE) and undergo an annual clinical breast examination (CBE) performed by a healthcare professional. Annual mammogram is recommended for women beginning age 40. According to the 2010 Philippine Cancer Facts and Estimates, national breast cancer awareness campaigns which do not include the provision of diagnosis and treatment are outdated and ineffective. It recommended that each province, city, municipality and barangay should establish and implement its own program for breast cancer diagnosis and treatment.

    For such a program to succeed and be sustainable, local government officials, insurance providers, NGOs and civic-minded individuals and organizations, health workers and medical specialty societies must work together in providing access to breast cancer screening and treatment.

    References:





    4. http://www.philhealth.gov.ph/news/2012/z_benefits.html

    For more Updates, follow us on Facebook

    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia

    Friday, May 20, 2016

    Mercy killing - A new lease of life : Palliative Medicine

    Dear Readers..!!! Thanks for visiting my blog...!!!

    Our Sincere Thanks to Dr. Gayatri Palat, MD for sharing with us.  


    Addressing the contentious issue of mercy killing, the government has come up with a draft Bill on passive euthanasia which will give a patient the right to withhold from medical treatment in case they are terminally ill.


    The Union Health Ministry has drafted and put up ‘The Medical Treatment of Terminally Ill Patients (Protection of Patients and Medical Practitioners) Bill’ in the public domain for consultation with stakeholders.


    The Bill intends to provide protection to patients and medical practitioners from liability in the context of withholding or withdrawing medical treatment, including life support systems, from those who are terminally ill. According to the Bill, every “competent” person, including minors aged over 16, has a right to decide on withholding or withdrawing medical treatment and to allow nature to take its own course or for starting medical treatment in case of terminal illness.

    The Bill goes on to say that such a decision will be binding on the medical practitioner. He or she has to inform the spouse, parents or any other close relative of the patient and desist from carrying out the decision for a period of three days after informing them.

    However, despite withdrawing the medical treatment, the said doctor can keep administering palliative care to the patient. The draft Bill gives legal cover to both patients and medical practitioners.

    The Medical Council of India has been given the authority to formulate guidelines from time to time for the guidance of medical practitioners and might review and modify the guidelines periodically.

    In case any patient is not competent enough to take a decision then his or her next of kin, including spouse, parents or sibling, can approach the High Court, which will have to take a decision within a period of one month.

    The government first attempted to formulate a law in 2006, based on a report of the Law Commission. However, the ministry had at that time decided not to take any action. The Supreme Court had laid down comprehensive guidelines in the Aruna Shanbaug case to process passive euthanasia. Active euthanasia is different from the passive form and involves injecting the patient with a lethal substance causing death in a painless manner.

    The Aruna Shanbaug story

    The debate on euthanasia caught the public attention in Aruna Shanbaug’s case. Aruna died in 2015 after being in a Permanent Vegetative State for over 40 years. While rejecting the plea for her mercy killing, SC laid out the first set of guidelines for euthanasia

    What happened to Aruna?

    Aruna, a nurse at King Edward Memorial Hospital in Mumbai, was sexually assaulted by a sweeper in 1973. He choked her with a dog chain causing severe brain damage. She was discovered only the next day.



    For more Updates, follow us on Facebook

    Happy Blogging...!!!

    Regards,
    Deepak Kumar Bandari,
    Pharm.D Intern,
    Vaagdevi College of Pharmacy - India
    Elsevier Student Ambassador - South Asia